HemeQuiz1 is a paid hematology and hematopathology quiz app for medical and laboratory science students on iOS.
Product velocity
Unknown
Daily rank 🇺🇸
—
Medical
Sentiment
5.0
15 reviews
Nemesis
Medical Terminology Quiz Game
The App DNA
What makes this app unique?
Medical students hire this tool to verify clinical knowledge via expert-edited explanations, ensuring accuracy for board exams and residency preparation.
For Medical, CLS, and MLT students, as well as residents and fellows specializing in hematology and hematopathology.
What does it look like?
Key features
Hundreds of hematology and hematopathology questions with explanations for correct and incorrect choices, curated by content experts.
Visual and numerical display of category completion status to monitor study progress.
Social leaderboard and multiplayer capability for competitive study sessions.
How much does it cost?
Paid model anchored at $1.99, leveraging the reputation of the Hematology Outlines educational series to drive conversion.
Velocity
Steady developmentShow more...
Who built it?
Hooman Rashidi
3 apps tracked · Medical
Hematology Outlines Atlas
Note Genie PlusUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for HemeQuiz1
How's the Medical market?
HemeQuiz1 maintains a niche presence in the medical education category, currently ranking #92 Paid in the US. The lack of updates since 2018 suggests a maintenance-mode strategy that risks losing ground to more frequently refreshed competitors.
Read the market outlookThe rivals identified
By Ameer Moosa
This app competes directly for the attention of medical students and trainees by offering a gamified approach to medical knowledge acquisition.
- Offers progressive level unlocking to drive user retention through a sense of achievement
- Utilizes a hint system to lower the barrier to entry for novice medical students
- Employs multi-strategy quiz modes that provide more variety than HemeQuiz1's static question bank
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for HemeQuiz1
Where is it heading?
The medical education market is shifting toward high-frequency, gamified study tools that offer offline utility for clinical environments. HemeQuiz1 remains exposed due to its static, outdated format, so the PM must pivot to a modern engagement model to prevent further loss of market share.
- The absence of updates since 2018 signals a lack of active investment, which erodes trust in clinical accuracy for medical students.
- Competitors with offline capabilities and gamified progression are siphoning the student demographic, accelerating the decline in chart visibility.
The SWOT
- Expert-edited clinical content provides high accuracy
- Hematology Outlines branding drives initial trust
- 17-category structure covers the full hematology curriculum
- Implement offline mode to capture clinical users
- Add pro-mode with advanced difficulty for residents
- Introduce freemium trial to widen top-of-funnel
Next best moves
Ship offline mode because clinical students require study tools in hospital settings without internet → increase retention in high-value user segment.
+ 2 more prioritized movesThe counter-intuitive read
The app's lack of updates is not just…
Read the full takeFeature gaps
Offline quiz engine (available in Nursing: Hematology Quiz) +1
Since the last report: The app's competitive position has declined due to a lack of updates since 2018, forcing a strategic pivot toward offline functionality and freemium models to address retention and discovery issues.
Bottom line
HemeQuiz1 holds a strong clinical reputation but lacks the engagement loops required to compete with modern gamified study tools, so the PM should prioritize offline functionality to secure its place in clinical workflows.
Unlock 3 critical frictions, 3 market threats, 2 more prioritized moves and the analyst’s take.
Access the full report for freeReport last updated